The FDA is Taking a Big Risk on AI
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
The FDA is Taking a Big Risk on AI
-
Narrado por:
-
De:
Acerca de esta escucha
Send us a text
The FDA is charging ahead with generative AI, claiming it can cut scientific review times from days to minutes. But is this innovation or recklessness?
In this episode of CareTalk, David Williams and John Driscoll debate whether the FDA’s rapid deployment of AI is a smart move or a potentially dangerous shortcut.
Stream our episode with FDA leader, Dr. Marty Makary, here.
🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter
Support the show
⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.